855 results on '"Goebeler M"'
Search Results
2. Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
3. Epidemiologie, Patientenlebensqualität und Behandlungskosten der Hidradenitis suppurativa/Acne inversa
4. 118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)
5. PB1334 Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases
6. Kutane Lymphome: Klinik – Diagnostik – Therapie
7. 584 Overview of the safety profile of efgartigimod from clinical trials in participants with diverse IgG–mediated autoimmune diseases
8. Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
9. Erkrankungen des Gefäßsystems
10. Erkrankungen des Bindegewebes und der Subkutis
11. Autoimmunerkrankungen der Haut
12. Entzündliche Hauterkrankungen
13. Zysten, Nävi und Tumoren der Haut
14. Sarkoidose: Dermatologischer Blick auf eine seltene Multisystemerkrankung
15. Progrediente Ulzerationen der Periorbita
16. Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
17. EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors
18. 729MO Final results of the first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in combination with nivolumab in subjects with solid tumors relapsed/refractory to prior anti-PD1/PD-L1 treatment
19. Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa
20. Impact of off‐label use regulations on patient care in dermatology – a prospective study of cost‐coverage applications filed by tertiary dermatology clinics throughout Germany
21. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
22. Erworbene bullöse Dermatosen
23. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
24. REINA - Retrospective Multicenter ADOReg Evaluation of Ipilimumab plus Nivolumab in Avelumab-refractory Merkel cell carcinoma
25. Lichenoide Erkrankungen
26. Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial
27. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway
28. Impaired FoxP3+ Treg function and epigenetic modulations at the FoxP3 enhancer, promotor and TSDR regions by Th17-inducing cytokines in patients with psoriatic arthritis
29. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa*
30. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
31. Endothelial cell activation and mononuclear cell infiltration during allergic and irritant contact dermatitis
32. Therapieresistente purulente Papeln und Knoten gluteal und im Bereich beider Oberschenkel
33. LB773 Treating pemphigus vulgaris (PV) and foliaceus (PF) by inhibiting the neonatal Fc receptor: Phase 2 multicentre open-label trial with efgartigimod
34. Erratum: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
35. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas
36. Cladosporium cladosporioides: a so far unidentified cause of white piedra
37. Bisphosphonat-induzierte orale Mundschleimhauterosionen: selten, häufig übersehen, jedoch einfach zu behandeln: FV04/10
38. Aktivierung des Inflammasoms in läsionaler Epidermis bei der Acne inversa: FV01/02
39. Zinkmangeldermatitis – eine wichtige Differentialdiagnose in der Geriatrie: DK02/02
40. Vaskulitiden: Klinik und Therapie: S09/03
41. Phlebologie an deutschen Hautkliniken: Eine Bestandsaufnahme im Auftrag der Deutschen Gesellschaft für Phlebologie
42. Ca 2+ signalling is critical for autoantibody‐induced blistering of human epidermis in pemphigus*
43. Asymptomatischer Nodus am Daumen einer älteren Frau
44. Erfolgreiche Therapie eines diskoiden Lupus erythematodes mit Efalizumab
45. Systemtherapie des metastasierten Uveamelanoms: Literatur-Review und Analyse klinischer Endpunkte: FV7
46. Multiple familiäre Trichoepitheliome (Brooke-Syndrom): Eine seltene Genodermatose mit möglicher periokulärer Manifestation
47. Proportions of regulatory T cells (Treg) and suppressive Treg function in patients with psoriasis arthritis (PsA) or spondyloarthritis (SpA) after switching to anti-IL-17 treatment
48. Dyskeratosis congenita bei einem 40-jährigen Patienten
49. Systemischer Lupus erythematodes
50. Therapie des Lichen planus pemphigoides durch Acitretin und pulsweise verabreichtes Kortikosteroid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.